Skip Navigation LinksHome > May 25, 2001 - Volume 15 - Issue 8 > Sperm mitochondrial DNA deletions as a consequence of long t...
AIDS:
Research Letters

Sperm mitochondrial DNA deletions as a consequence of long term highly active antiretroviral therapy

White, David J.a; Mital, Dushyanta; Taylor, Stevena; St John, Justin C.b

Free Access
Article Outline
Collapse Box

Author Information

aDepartment of Infection, Birmingham Heartlands Hospital, Birmingham, UK; bReproductive Biology and Genetics Group, Department of Medicine, University of Birmingham, Birmingham, UK.

Presented at the 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Toronto, Canada, 13–15 September 2000 [Abstract P23, 37–38].

Informed consent was obtained from all patients enrolled in this study and the ethical guidelines of Birmingham Heartlands Hospital were followed in the conduct of this clinical research.

Received: 25 October 2000;

revised: 5 January 2001; accepted: 10 January 2001.

Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis for those infected with HIV-1 [1]. However, with the use of long-term HAART, a variety of side-effects may occur, for example lactic acidosis [2], peripheral neuropathy [3], and probably lipo-atrophy [4]. Nucleoside anti-retroviral agents are thought to generate either depleted [5] or mutated mitochondrial DNA either by inhibition of mitochondrial-specific polymerase γ[6] or through the increased generation of free radicals [7]. Different combinations of drug therapy are thought to have varying quantitative toxic effects on these two causes of mtDNA damage [8]. However, research has been limited by the lack of easily obtainable tissue as a result of the invasive nature of the clinical procedure. Importantly, however, human spermatozoa are an easily obtainable clinical material that is susceptible to the generation of multiple mtDNA deletions [9,10]. In order to determine whether spermatozoa could provide clinically relevant data as to the effects of HAART on individual patients, we used Long polymerase chain reaction (PCR) [11] on a series of sperm samples to detect the presence of multiple mtDNA deletions.

We analysed sperm samples produced by masturbation from 10 men attending our clinic. Four of the men had never taken antiretroviral therapy whereas the others (n = 6) took a combination of HAART. For one of the men, we analysed sperm samples at three different times points over 14 months (see Table 1). From each of the sperm samples, total DNA was isolated using the Puregene DNA Isolation Kit (Gentra Systems, Minneapolis, MN, USA). Deletions were detected using Long PCR to amplify 10.6 kb of the mitochondrial genome with primers specific to the region of the genome most prone to mtDNA deletion (D6: 5′–TCT AGA GCC CAC TGT AAA G–3′ and R10: 5′–AGT GCA TAC CGC CAA AAG A–3′) [9]. The resulting PCR products were resolved on 0.8% agarose gels. The results are presented in Table 1.

Table 1
Table 1
Image Tools

Patient 1 was initially treated with lamivudine/delavirdine/indinavir, which was then quickly modified to stavudine, didanosine, nevirapine didanosine/stavudine/nevirapine/hydroxyurea. After 24 weeks, treatment was again changed to zidovudine/lamivudine/nevirapine because of side-effects. Before treatment, no mtDNA deletions were detected. However, at 6 months, this patient developed multiple mtDNA deletions, which persisted and became more clearly evident at 14 months of treatment. Of the four men who had never taken antiretroviral agents when the samples were analysed, only one (patient 5) of these had observable multiple mtDNA deletions. The two patients on HAART for less than 12 months harboured no mtDNA deletions. However, three men on HAART for more than 12 months possessed multiple mtDNA deletions. Interestingly, these three patients also presented with clinically evident lipodystrophy [4].

The proportion of patients with mtDNA deletions was significantly greater in those patients who had taken HAART for more than 12 months compared with those who had taken HAART for less than 12 months (two-tailed Fisher's exact test P < 0.05). Those patients who harboured mtDNA deletions had taken either stavudine [12] or didanosine, but only one patient had taken only zidovudine/stavudine. Furthermore, none of these patients had taken protease inhibitors.

We have demonstrated the propagation of multiple mtDNA deletions as a result of long-term HAART in sperm samples. These deletions may arise through damage to the mitochondrial genome of their precursor spermatogonial cells, resulting in the amplification of these deleted molecules [13]. De novo multiple mtDNA deletions can only occur in cells that frequently replicate mtDNA. Spermatozoa are produced approximately 60 days before ejaculation, and it is common to detect both normal and abnormal spermatozoa in semen samples [14]. It is evident from various studies that abnormal cells will undergo apoptosis [15] and subsequent phagocytosis [16]. However, abnormal spermatozoa may be the consequence of an abortive mitochondrial-mediated apoptotic event [17] at the stem cell level accounting for the presence of both the abnormal and normal populations of mature sperm cells in samples analysed. The results of this study strongly suggest that an analysis of sperm mtDNA should be included in further studies of HAART-mediated mitochondrial disease.

Back to Top | Article Outline
Acknowledgements

The authors would like to thank the patients and staff of Birmingham Heartlands Hospital and the Department of Andrology (University of Birmingham), especially Dr Susan Drake and Dr Matthew Tomlinson for all their help and contribution to our study.

David J. Whitea

Dushyant Mitala

Steven Taylora

Justin C. St Johnb

Back to Top | Article Outline

References

1. Gazzard BG, Moyle G, Johnson M, et al. BHIVA Guidelines. BHIVA Guidelines 1999.

2. Roy PM, Gouello JP, Pennison-Besnier I, Chennebault JM. Severe lactic acidosis induced by nucleoside analogues in an HIV infected man. Ann Emerg Med 1999, 34: 282 –284.

3. Moyle G, Sadler M. Peripheral neuropathy with nucleoside anti-retrovirals. Drug Safety 1998, 19: 481 –494.

4. First International Workshop on Adverse Reactions and Lipodystrophy in HIV. San Diego, US. Consensus – Antivir Ther Suppl 1999, 4:75–77.

5. Brinkman K, Smeitink JAM, Romijn JA, Reiss P. Mitochondrial toxicity induced by NRTIs is a key factor in the pathogenesis of antiretroviral related lipodystrophy. Lancet 1999, 354: 1112 –1115.

6. Arnaudo E, Dalakas M, Shanske S, Moraes CT, Dimauro S, Schon EA. Depletion of muscle mitochondrial DNA in AIDS patient with zidovudine-induced myopathy. Lancet 1991, 337: 508 –510.

7. Hayakawa M, Ogawa T, Sugiyama S, Tanaka M, Ozawa T. Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver DNA by administration of azidothymidine. Biochem Biophys Res Commun 1991, 176: 87 –93.

8. Chen CH, Vazquez-Padua M, Cheng YC. Effect of anti-HIV nucleoside analogues on mitochondrial DNA and its implication for delayed toxicity. Mol Pharmacol 1991, 39: 625 –628.

9. Lestienne P, Reynier P, Chretien MF, Pennison-Besnier I, Malthiery Y, Rohmer V. Oligoasthenospermia associated with multiple mitochondrial DNA rearrangements. Mol Hum Reprod 1997, 3: 811 –814.

10. Kao SH, Chao HT, Wei YH. Multiple deletions of mitochondrial DNA are associated with the decline of motility and fertility of human spermatozoa. Mol Hum Reprod 1998, 4: 657 –666.

11. Ferlin T, Guironnet G, Barnoux MC, Dumoulin R, Stepien G, Mousson B. Detection of mitochondrial DNA deletions by a screening procedure using the polymerase chain reaction. Mol Cell Biochem 1997, 174: 221 –225.

12. Miro O, Gomez M, Pedrol E, Cardellach F, Nunes V, Casademont J. Respiratory chain dysfunction associated with multiple mitochondrial DNA deletions in antiretroviral therapy related lipodystrophy. AIDS 2000, 14: 1855 –1857.

13. St John JC, Sakkas D, Barratt CLR. A role for mitochondrial DNA in sperm survival. J Androl 2000, 21: 189 –199.

14. Hermo L, Clermont Y. How are germ cells produced and what factors control their production? In:Handbook of Andrology. Lawrence, KS, USA: The American Society of Andrology, Allen Press, Inc.; 1995. pp. 13 –16.

15. Domingo P, Matias-Guiu X, Pujol RM, Francia E, Lagarda E, Sambeat MA, Vazquez G. Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS 1999, 13: 2261 –2267.

16. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000, 405: 85 –90.

17. Sakkas D, Mariethoz E, St John JC. Abnormal sperm parameters in humans are indicative of an abortive apoptotic mechanism linked to the Fas-mediated pathway. Exp Cell Res 1999, 251: 350 –355.

Cited By:

This article has been cited 21 time(s).

Current Pharmaceutical Design
Viruses in semen and male genital tissues - consequences for the reproductive system and therapeutic perspectives
Dejucq-Rainsford, N; Jegou, B
Current Pharmaceutical Design, 10(5): 557-575.

International Journal of Andrology
The impact of mitochondrial genetics on male infertility
St John, JC; Jokhi, RP; Barratt, CLR
International Journal of Andrology, 28(2): 65-73.
10.1111/j.1365-2605.2005.00515.x
CrossRef
Human Reproduction
Ooplasm donation in humans - The need to investigate the transmission of mitochondrial DNA following cytoplasmic transfer
St John, JC
Human Reproduction, 17(8): 1954-1958.

Antiviral Therapy
Mitochondrial effects of antiretroviral therapies in asymptomatic patients
Lopez, S; Miro, O; Martinez, E; Pedrol, E; Rodriguez-Santiago, B; Milinkovic, A; Soler, A; Garcia-Viejo, MA; Nunes, V; Casademont, J; Gatell, JM; Cardellach, F
Antiviral Therapy, 9(1): 47-55.

Antiviral Therapy
Mitochondrial studies in HAART-related lipodystrophy: from experimental hypothesis to clinical findings
Miro, O; Lopez, S; Cardellach, F; Casademont, J
Antiviral Therapy, 10(): M73-M81.

Antiviral Therapy
Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications
Tarr, PE; Telenti, A
Antiviral Therapy, 12(7): 999-1013.

Human Reproduction Update
Transmission of mitochondrial DNA following assisted reproduction and nuclear transfer
Spikings, EC; Alderson, J; St John, JC
Human Reproduction Update, 12(4): 401-415.
10.1093/humupd/dml011
CrossRef
Antiviral Therapy
Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women
Lopez, S; Coll, O; Durban, M; Hernandez, S; Vidal, R; Suy, A; Moren, C; Casademont, J; Cardellach, F; Mataro, D; Miro, O; Garrabou, G
Antiviral Therapy, 13(6): 833-838.

Theriogenology
The transmission of mitochondrial DNA following assisted reproductive techniques
St John, JC
Theriogenology, 57(1): 109-123.

Febs Letters
Mitochondria from ejaculated human spermatozoa do not synthesize proteins
Diez-Sanchez, C; Ruiz-Pesini, E; Montoya, J; Perez-Martos, A; Enriquez, JA; Lopez-Perez, MJ
Febs Letters, 553(): 205-208.
10.1016/S0014-5793(03)01013-5
CrossRef
Human Reproduction Update
Reproduction and fertility in human immunodeficiency virus type-1 infection
van Leeuwen, E; Prins, JM; Jurriaans, S; Boer, K; Reiss, P; Repping, S; van der Veen, F
Human Reproduction Update, 13(2): 197-206.
10.1093/humupd/dml052
CrossRef
Cloning and Stem Cells
The expression of mitochondrial DNA transcription factors during early cardiomyocyte in vitro differentiation from human embryonic stem cells
St John, JC; Ramalho-Santos, J; Gray, HL; Petrosko, P; Rawe, VY; Navara, CS; Simerly, CR; Schatten, GP
Cloning and Stem Cells, 7(3): 141-153.

Fertility and Sterility
Mitochondrial content reflects oocyte variability and fertilization outcome
Santos, TA; El Shourbagy, S; St John, JC
Fertility and Sterility, 85(3): 584-591.
10.1016/j.fertnstert.2005.09.017
CrossRef
Journal of Andrology
Decreased semen volume and spermatozoa motility in HIV-1-infected patients under antiretroviral treatment
Bujan, L; Sergerie, M; Moinard, N; Martinet, S; Porte, L; Massip, P; Pasquier, C; Daudin, M
Journal of Andrology, 28(3): 444-452.
10.2164/jandrol.106.001529
CrossRef
Biology of Reproduction
Mitochondrial DNA content of human spermatozoa
Diez-Sanchez, C; Ruiz-Pesini, E; Lapena, AC; Montoya, J; Perez-Martos, A; Enriquez, JA; Lopez-Perez, MJ
Biology of Reproduction, 68(1): 180-185.
10.1095/biolreprod.102.005140
CrossRef
Mitochondrion
HIV-associated dementia, mitochondrial dysfunction, and oxidative stress
Valcour, V; Shiramizu, B
Mitochondrion, 4(): 119-129.
10.1016/j.mito.2004.05.009
CrossRef
Biochimica Et Biophysica Acta-Bioenergetics
Anti-HIV drugs and the mitochondria
Pinti, M; Salomoni, P; Cossarizza, A
Biochimica Et Biophysica Acta-Bioenergetics, 1757(): 700-707.
10.1016/j.bbabio.2006.05.001
CrossRef
International Journal of Andrology
Deficit in cytochrome c oxidase activity induced in rat sperm mitochondria by in vivo exposure to zidovudine
Leandri, RD; Dulioust, E; Benbrik, E; Jouannet, P; De Almeida, M
International Journal of Andrology, 26(5): 305-309.

Reproductive Biomedicine Online
The potential risks of abnormal transmission of mtDNA through assisted reproductive technologies
St John, JC; Lloyd, R; El Shourbagy, S
Reproductive Biomedicine Online, 8(1): 34-44.

AIDS
Mitochondrial DNA and sperm quality in patients on antiretroviral therapy – response
Mital, D; White, DJ; John, JC
AIDS, 18(6): 963.

PDF (131)
Current Opinion in Infectious Diseases
Tests for mitochondrial function and DNA: potentials and pitfalls
Cossarizza, A
Current Opinion in Infectious Diseases, 16(1): 5-10.

PDF (91)
Back to Top | Article Outline

© 2001 Lippincott Williams & Wilkins, Inc.

Login